STUDY BIOCHEMICAL PARAMETER LDH IN OVARIAN TUMORS BEFORE AND AFTER CHEMOTHERAPY

Journal Title: International Journal Of Advances In Surgery - Year 2019, Vol 3, Issue 1

Abstract

Serum LDH elevations occur in a variety of clinical conditions including of MI, hemolysis and disorders of the liver, kidneys, lung and muscle. Literature concluded that serum LDH is relevant in the diagnosis of MI, hemolytic anemia, ovarian dysgerminoma and testicular germ cell tumor. Although not that relevant for epithelial ovarian cancer, LDH is considered important in the follow up of dysgerminoma for assessing response to therapy and prognostification of disease. The current study designed with an aim to explore the changes in LDH levels of malignant and benign ovarian tumors pre therapy and post therapy. A study was conducted on 40 patients suffering from ovarian tumors (Benign and Malignant) who had reported to Rangaraya Medical College hospital, Kakinada. The mean duration of symptoms was 12.6 ± 20.89 weeks (range 0.4- 104 weeks) and the median was 6.5 weeks in our cohort of patients. The mean duration of symptoms for benign (n=11) tumors was 23.1 ± 33.1 weeks whereas for malignant (n=29) tumors the duration of symptoms was 8.62 ± 12.50 weeks. All patients with ovarian tumours (both malignant & benign) had a pretreatment mean ± SD value of CA125 as 767 ±1069 U/ml which reduced to a mean± SD value of 46.28 ± 41.28 U/ml post treatment (p< 0.0004). A significant change was found in the levels of LDH (Pretreatment value of 479±320.6 U/L and post treatment levels of 182.8±107U/L) (P<0.0001). When compared to healthy controls (mean CA-125:15.48 (range: 5.7-22) & mean LDH: 182.8 (range:140-300), ovarian tumour patients had a higher CA-125 & LDH levels(mean CA-125: 767 & mean LDH:479.36). We also tried to see the correlation between CA-125 and LDH both in benign and malignant ovarian tumours. A positive correlation was found between CA125 levels and LDH in malignant ovarian tumours. In benign tumours, a positive correlation was found between CA125 and LDH

Authors and Affiliations

Dr. G. Veena Murty, Dr. Prem Kumar, Dr. G. Rajeswari

Keywords

Related Articles

ROLE OF EARLY SECOND TURBT IN DETECTION OF RECURRENCE AND DISEASE PROGRESSION IN T1 TCC BLADDER

Introduction : Majority of the Bladder cancers are non-muscle invasive T1 tumours which have a high propensity of recurrence and at times may be under staged during the initial trans-urethral resection. This study aims t...

FUNCTIONAL OUTCOME OF DISPLACED MIDSHAFT CLAVICLE FRACTURES TREATED BY PLATE OSTEOSYNTHESIS VERSUS MINIMALLY INVASIVE TITANIUM ELASTIC NAIL FIXATION.

The management of clavicle fractures has dramatically changed over the last decade. Classic teaching had suggested that even if both ends of the clavicle were to be widely separated, it wound go on to heal. However longi...

TO STUDY THE CLINICAL PROFILE OF LENS INDUCED GLAUCOMA IN A TERTIARY CARE CENTRE IN WESTERN MAHARASHTRA

Introduction- Aim of this research was to study the clinical profile and risk factors associated with lens induced glaucoma in a tertiary care centre in western Maharashtra, To study the demography of patients with LIG,...

TO STUDY THE OUTCOSME FOLLOWING COMBINED MANAGEMENT OF FRACTURE DISTAL END OF FEMU WITH IPSILATERAL PATELLAR FRACTURE: A PROSPECTIVE AND DESCRIPTIVE STUDY

AIM: To study the outcome following combined management of fracture distal end of femur with ipsilateral patellar fracture. METHODS: A hospital based Prospective, Interventional and Descriptive study was done at Departme...

OUTCOME ANALYSIS OF BUCCAL MUCOSA URETHROPLASTY IN A TERTIARY CARE CENTRE

Introduction: Urethral strictures are difficult to cure. Treatment options include simple dilation, optical internal urethrotomy, and a variety of urethral reconstructive techniques such as substitution urethroplasty. Th...

Download PDF file
  • EP ID EP638300
  • DOI -
  • Views 55
  • Downloads 0

How To Cite

Dr. G. Veena Murty, Dr. Prem Kumar, Dr. G. Rajeswari (2019). STUDY BIOCHEMICAL PARAMETER LDH IN OVARIAN TUMORS BEFORE AND AFTER CHEMOTHERAPY. International Journal Of Advances In Surgery, 3(1), 1-4. https://europub.co.uk/articles/-A-638300